Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Shareholders' Deficit (Unaudited)

v3.20.1
Condensed Consolidated Statements of Changes In Shareholders' Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 80,459 $ 31,863,693 $ (32,759,275) $ (815,123)
Balance, shares at Dec. 31, 2018 80,459,006      
Common shares issued for services and prepaid services $ 685 113,775 114,460
Common shares issued for services and prepaid services, shares 685,060      
Accretion of stock-based compensation   909,375   909,375
Accretion of stock option expense 586,934 586,934
Stock option exercise compensation 7,500 7,500
Net loss (2,360,423) (2,360,423)
Balance at Mar. 31, 2019 $ 81,144 33,481,277 (35,119,698) (1,557,277)
Balance, shares at Mar. 31, 2019 81,144,066      
Balance at Dec. 31, 2019 $ 116,750 37,266,328 (40,000,015) (2,616,937)
Balance, shares at Dec. 31, 2019 116,749,633      
Shares issued for conversion of accounts payable $ 151 5,907 6,058
Shares issued for conversion of accounts payable, shares 151,456      
Common shares issued for cash $ 7,000 273,000 280,000
Common shares issued for cash, shares 7,000,000      
Accretion of stock-based compensation   170,072   170,072
Common shares issued for conversion of accrued interest $ 475 12,245 12,720
Common shares issued for conversion of accrued interest, shares 475,000      
Common shares issued for services $ 1,250 48,750 50,000
Common shares issued for services, shares 1,250,000      
Issuance of warrants in connection with convertible debt 8,676 8,676
Accretion of stock option expense 191,308 191,308
Net loss (1,508,288) (1,508,288)
Balance at Mar. 31, 2020 $ 125,626 $ 37,976,286 $ (41,508,303) $ (3,406,391)
Balance, shares at Mar. 31, 2020 125,626,089